Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $52.00 at Citigroup

Omega Healthcare Investors (NYSE:OHIFree Report) had its price objective lifted by Citigroup from $50.00 to $52.00 in a report published on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the real estate investment trust’s stock.

A number of other analysts have also recently commented on the company. Scotiabank lifted their price objective on Omega Healthcare Investors from $45.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Cantor Fitzgerald lifted their price objective on Omega Healthcare Investors from $50.00 to $52.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Bank of America reiterated an “underperform” rating and set a $46.00 price objective (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. UBS Group reiterated a “buy” rating and set a $52.00 price objective on shares of Omega Healthcare Investors in a research report on Friday, February 6th. Finally, Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $48.00.

Read Our Latest Stock Analysis on Omega Healthcare Investors

Omega Healthcare Investors Price Performance

Shares of OHI stock traded up $0.04 during mid-day trading on Friday, reaching $47.01. The stock had a trading volume of 1,897,540 shares, compared to its average volume of 2,133,540. Omega Healthcare Investors has a 12-month low of $35.08 and a 12-month high of $49.14. The company has a market cap of $14.00 billion, a P/E ratio of 22.71, a price-to-earnings-growth ratio of 2.10 and a beta of 0.59. The business has a 50-day simple moving average of $46.38 and a 200 day simple moving average of $44.80. The company has a current ratio of 5.32, a quick ratio of 5.04 and a debt-to-equity ratio of 0.81.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.96 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same quarter in the prior year, the business earned $0.75 EPS. The company’s quarterly revenue was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, sell-side analysts anticipate that Omega Healthcare Investors will post 3.06 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, May 4th will be paid a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 5.7%. The ex-dividend date of this dividend is Monday, May 4th. Omega Healthcare Investors’s payout ratio is currently 129.47%.

Hedge Funds Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently modified their holdings of the company. Mutual Advisors LLC lifted its stake in shares of Omega Healthcare Investors by 8.5% in the 3rd quarter. Mutual Advisors LLC now owns 327,383 shares of the real estate investment trust’s stock valued at $13,321,000 after purchasing an additional 25,565 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Omega Healthcare Investors by 6.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 3,761,216 shares of the real estate investment trust’s stock worth $158,799,000 after acquiring an additional 239,134 shares during the period. CPC Advisors LLC purchased a new position in Omega Healthcare Investors in the 4th quarter worth approximately $3,050,000. Bright Futures Wealth Management LLC. purchased a new position in Omega Healthcare Investors in the 3rd quarter worth approximately $458,000. Finally, JPMorgan Chase & Co. boosted its holdings in Omega Healthcare Investors by 77.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after acquiring an additional 1,496,059 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Recommended Stories

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.